| Iron Oxide Nanoparticles as T1 Contrast Agents for Magnetic Resonance Imaging: Fundamentals, Challenges, Applications, and Prospectives M Jeon, MV Halbert, ZR Stephen, M Zhang Advanced materials 33 (23), 1906539, 2021 | 372 | 2021 |
| Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells Q Mu, FM Kievit, RJ Kant, G Lin, M Jeon, M Zhang Nanoscale 7 (43), 18010-18014, 2015 | 130 | 2015 |
| Nanoparticle‐mediated target delivery of TRAIL as gene therapy for glioblastoma K Wang, FM Kievit, M Jeon, JR Silber, RG Ellenbogen, M Zhang Advanced healthcare materials 4 (17), 2719-2726, 2015 | 88 | 2015 |
| Approach to rapid synthesis and functionalization of iron oxide nanoparticles for high gene transfection ZR Stephen, CJ Dayringer, JJ Lim, RA Revia, MV Halbert, M Jeon, ... ACS applied materials & interfaces 8 (10), 6320-6328, 2016 | 75 | 2016 |
| Iron‐oxide‐based nanovector for tumor targeted siRNA delivery in an orthotopic hepatocellular carcinoma xenograft mouse model K Wang, FM Kievit, JG Sham, M Jeon, ZR Stephen, A Bakthavatsalam, ... Small 12 (4), 477-487, 2016 | 72 | 2016 |
| Stable and efficient Paclitaxel nanoparticles for targeted glioblastoma therapy Q Mu, M Jeon, MH Hsiao, VK Patton, K Wang, OW Press, M Zhang Advanced healthcare materials 4 (8), 1236-1245, 2015 | 63 | 2015 |
| Preloading of Hydrophobic Anticancer Drug into Multifunctional Nanocarrier for Multimodal Imaging, NIR‐Responsive Drug Release, and Synergistic Therapy H Wang, K Wang, B Tian, R Revia, Q Mu, M Jeon, FC Chang, M Zhang Small 12 (46), 6388-6397, 2016 | 58 | 2016 |
| Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer Q Mu, G Lin, M Jeon, H Wang, FC Chang, RA Revia, J Yu, M Zhang Materials Today 50, 149-169, 2021 | 57 | 2021 |
| Nanoparticle biokinetics in mice and nonhuman primates PA Chiarelli, RA Revia, ZR Stephen, K Wang, M Jeon, V Nelson, ... ACS nano 11 (9), 9514-9524, 2017 | 45 | 2017 |
| Time-resolved MRI assessment of convection-enhanced delivery by targeted and nontargeted nanoparticles in a human glioblastoma mouse model ZR Stephen, PA Chiarelli, RA Revia, K Wang, F Kievit, C Dayringer, ... Cancer research 79 (18), 4776-4786, 2019 | 40 | 2019 |
| Catalase‐functionalized iron oxide nanoparticles reverse hypoxia‐induced chemotherapeutic resistance TY Yen, ZR Stephen, G Lin, Q Mu, M Jeon, S Untoro, P Welsh, M Zhang Advanced healthcare materials 8 (20), 1900826, 2019 | 33 | 2019 |
| Paclitaxel‐loaded iron oxide nanoparticles for targeted breast cancer therapy M Jeon, G Lin, ZR Stephen, FL Kato, M Zhang Advanced Therapeutics 2 (12), 1900081, 2019 | 31 | 2019 |
| pH-sensitive O6-benzylguanosine polymer modified magnetic nanoparticles for treatment of glioblastomas ZR Stephen, RN Gebhart, M Jeon, AA Blair, RG Ellenbogen, JR Silber, ... Bioconjugate chemistry 28 (1), 194-202, 2017 | 19 | 2017 |
| A highly selective iron oxide-based imaging nanoparticle for long-term monitoring of drug-induced tumor cell apoptosis G Lin, Q Mu, R Revia, Z Stephen, M Jeon, M Zhang Biomaterials science 9 (2), 471-481, 2021 | 6 | 2021 |
| Cocaine analogue conjugated magnetic nanoparticles for labeling and imaging dopaminergic neurons M Jeon, G Lin, ZR Stephen, JE Vechey, M Singh, R Revia, AH Newman, ... Biomaterials science 8 (15), 4166-4175, 2020 | 2 | 2020 |
| Iron Oxide Nanoparticles for Targeted Cellular Imaging and Drug Delivery M Jeon | | 2019 |
